CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY

被引：0

作者：

HEIMANS, JJ ^{[1
]}

DRUKARCH, B ^{[1
]}

MATTHAEI, I ^{[1
]}

IJFF, GA ^{[1
]}

BERTELSMANN, FW ^{[1
]}

STRIJERS, RLM ^{[1
]}

NAUTA, J ^{[1
]}

机构：

[1] FREE UNIV AMSTERDAM HOSP,DEPT THEORY MED,1007 MB AMSTERDAM,NETHERLANDS

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 84卷 / 06期

关键词：

DIABETIC NEUROPATHY; THERAPY; CYCLANDELATE;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Cyclandelate has the ability to improve the rheological properties of the blood and therefore may improve blood supply of peripheral nerves. Previous studies in diabetic neuropathy have shown beneficial effects of the drug. We performed a double-blind, placebo-controlled, cross-over study in 40 diabetic patients with cyclandelate in a dose of 1600 mg daily. Motor and sensory nerve conduction velocities, late responses, thermal discrimination thresholds, vibration perception thresholds and pain scores were studied. We were not able to show any positive effect of the drug and therefore conclude that cyclandelate is not effective in the treatment of diabetic neuropathy.

引用

页码：483 / 486

页数：4

共 50 条

[21] A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy
Grosskopf, J.
Mazzola, J.
Wan, Y.
Hopwood, M.
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (03): : 177 - 180
[22] Treatment of functional dyspepsia with sertraline: A double-blind randomized placebo-controlled pilot study
Tan, Victoria P. Y.
Cheung, Tin K.
Wong, Wai M.
Pang, Roberta
Wong, Benjamin C. Y.
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6127 - 6133
[23] Vardenafil for the Treatment of Raynaud Phenomenon: A Randomized, Double-blind, Placebo-Controlled Crossover Study
Caglayan, Evren
Axmann, Sarah
Hellmich, Martin
Moinzadeh, Pia
Rosenkranz, Stephan
ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (15) : 1182 - 1184
[24] Effect of steroids for nasal polyposis surgery: A placebo-controlled, randomized, double-blind study
Ecevit, Mustafa Cenk
Erdag, Taner Kemal
Dogan, Ersoy
Sutay, Semih
LARYNGOSCOPE, 2015, 125 (09) : 2041 - 2045
[25] Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months
Stirban, Ovidiu Alin
Zeller-Stefan, Helga
Schumacher, Jochen
Gaus, Wilhelm
Ziegler, Dan
Schuerholz, Thomas
Pop-Busui, Rodica
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
[26] Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
Mollace, Rocco
Gliozzi, Micaela
Macri, Roberta
Tavernese, Annamaria
Musolino, Vincenzo
Carresi, Cristina
Maiuolo, Jessica
Muscoli, Carolina
Tomino, Carlo
Rosano, Giuseppe Maria
Fini, Massimo
Volterrani, Maurizio
Silvestrini, Bruno
Mollace, Vincenzo
PHARMACEUTICS, 2022, 14 (01)
[27] THE EFFECT OF GAMMA-LINOLENIC ACID ON HUMAN DIABETIC PERIPHERAL NEUROPATHY - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
JAMAL, GA
CARMICHAEL, H
DIABETIC MEDICINE, 1990, 7 (04) : 319 - 323
[28] Pathophysiology and psychopharmacology of dementia - A new study design .2. Cyclandelate treatment - A placebo-controlled double-blind clinical trial
Schellenberg, R
Todorova, A
Wedekind, W
Schober, F
Dimpfel, W
NEUROPSYCHOBIOLOGY, 1997, 35 (03) : 132 - 142
[29] Peripheral pulsed electromagnetic fields may reduce the placebo effect in migraine patients that do not respond to the sham intervention in a randomized, placebo-controlled, double-blind, cross-over clinical trial
San-Juan, Daniel
Pon, Ana Aurora L.
Pohls, Fernando Z.
de Dios Del Castillo-Calcaneo, Juan
Perez-Neri, Ivan
Rios, Camilo
COMPLEMENTARY THERAPIES IN MEDICINE, 2012, 20 (1-2) : 31 - 37
[30] Analgesic effect of duloxetine compared to nortryptiline in patients with painful neuropathy: A randomized, double-blind, placebo-controlled trial
Bayani, Mohammadali
Moazammi, Babak
Fadaee-Jouybari, Farshad
Babaei, Mansour
Ahmadi-Ahangar, Alijan
Saadat, Payam
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2021, 12 (01) : 29 - 34

← 1 2 3 4 5 →